Join the 'Anal Fissure and Fistula' group to help and get support from people like you.
Anal Fissure and Fistula News
Related terms: Anal Fissure, Anal Fistula
Posted 26 May 2017 by Drugs.com
FRIDAY, May 26, 2017 – A new genetic test may detect anal cancer, a disease that's become more common in women, gay and bisexual men, and people with HIV. "If other studies confirm and build upon these findings, this promising research could be used to develop a less invasive method to help doctors identify people who are at a higher risk of anal cancer and avoid unnecessary procedures for those ...
Posted 2 Nov 2016 by Drugs.com
WEDNESDAY, Nov. 2, 2016 – Anal cancer rates are on the rise in many countries. But vaccination against human papillomavirus (HPV) – a virus linked to the development of anal cancer – may help curb rates of the disease, a new study suggests. Researchers looked at data from the International Agency for Research on Cancer. The data included 18 countries. The investigators found that anal cancer ...
Posted 25 Jan 2016 by Drugs.com
MONDAY, Jan. 25, 2016 – Colon cancer rates are rising among men and women under 50, the age at which guidelines recommend screenings start, a new analysis shows. One in seven colon cancer patients is under 50. Younger patients are more likely to have advanced stage cancer, but they live slightly longer without a cancer recurrence because they are treated aggressively, the researchers reported. ...
Posted 10 Aug 2015 by Drugs.com
-- While everyone has intestinal gas, some people have severe bloating that causes discomfort and other problems. The Mayo Clinic mentions these warning signs that you may need to see a doctor: Intestinal gas that is persistent and severe. Intestinal gas that occurs with vomiting. Long-term diarrhea, bloody stool or constipation. Weight loss for no apparent reason. Heartburn.
ProStrakan Receives FDA Approval for Rectiv for the Treatment of Moderate to Severe Pain Associated With Chronic Anal Fissures
Posted 29 Jun 2011 by Drugs.com
GALASHIELS, Scotland, and BEDMINSTER, N.J., June 22, 2011 /PRNewswire/ – ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd., and an international specialty pharmaceutical company, today announces that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv (nitroglycerin) Ointment 0.4 % for the treatment of moderate to severe pain associated with ...